类器官构建者。 - Suppr

Suppr

超能文献

The organoid architect.

作者信息

Sinha Gunjan

机构信息

Utrecht, the Netherlands.

出版信息

Science. 2017 Aug 25;357(6353):746-749. doi: 10.1126/science.357.6353.746.

DOI:10.1126/science.357.6353.746

PMID:28839056

Abstract

摘要

相似文献

The organoid architect.

Science. 2017 Aug 25;357(6353):746-749. doi: 10.1126/science.357.6353.746.

A combination therapy for cystic fibrosis.

Cell. 2015 Sep 24;163(1):17. doi: 10.1016/j.cell.2015.09.003.

PharmGKB summary: very important pharmacogene information for CFTR.

Pharmacogenet Genomics. 2015 Mar;25(3):149-56. doi: 10.1097/FPC.0000000000000112.

Aquagenic wrinkling of the palms in a patient with cystic fibrosis.

N Engl J Med. 2013 Dec 12;369(24):2362-3. doi: 10.1056/NEJMc1308349.

False dawn for cystic fibrosis disease modifiers?

Nat Rev Drug Discov. 2014 Oct;13(10):713-4. doi: 10.1038/nrd4456.

Cystic fibrosis transmembrane conductance regulator biomarkers in 'real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?

Ther Adv Respir Dis. 2015 Aug;9(4):198-200. doi: 10.1177/1753465815579364.

Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis.

Sci Transl Med. 2016 Jun 22;8(344):344ra84. doi: 10.1126/scitranslmed.aad8278.

Breathing easier with combinations.

Nat Biotechnol. 2015 Nov;33(11):1128-30. doi: 10.1038/nbt.3397.

CFTR potentiators: not an open and shut case.

Sci Transl Med. 2014 Jul 23;6(246):246fs27. doi: 10.1126/scitranslmed.3009674.

Lumacaftor alone and combined with ivacaftor: preclinical and clinical trial experience of F508del CFTR correction.

Expert Rev Respir Med. 2016;10(1):5-17. doi: 10.1586/17476348.2016.1122527. Epub 2015 Dec 9.

引用本文的文献

Patient-Derived Tumor Organoids: A Platform for Precision Therapy of Colorectal Cancer.

Cell Transplant. 2025 Jan-Dec;34:9636897251314645. doi: 10.1177/09636897251314645.

Landscape of human organoids: Ideal model in clinics and research.

Innovation (Camb). 2024 Apr 1;5(3):100620. doi: 10.1016/j.xinn.2024.100620. eCollection 2024 May 6.

3-D retina organoids: Building platforms for therapies of the future.

Cell Med. 2018 Jun 8;10:2155179018773758. doi: 10.1177/2155179018773758. eCollection 2018.

Copper Transport and Disease: What Can We Learn from Organoids?

Annu Rev Nutr. 2019 Aug 21;39:75-94. doi: 10.1146/annurev-nutr-082018-124242. Epub 2019 May 31.

Organoids Provide an Important Window on Inflammation in Cancer.

Cancers (Basel). 2018 May 21;10(5):151. doi: 10.3390/cancers10050151.

Scalable Production and Cryostorage of Organoids Using Core-Shell Decoupled Hydrogel Capsules.

Adv Biosyst. 2017 Dec;1(12). doi: 10.1002/adbi.201700165. Epub 2017 Nov 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The organoid architect.

Science. 2017 Aug 25;357(6353):746-749. doi: 10.1126/science.357.6353.746.

A combination therapy for cystic fibrosis.

Cell. 2015 Sep 24;163(1):17. doi: 10.1016/j.cell.2015.09.003.

PharmGKB summary: very important pharmacogene information for CFTR.

Pharmacogenet Genomics. 2015 Mar;25(3):149-56. doi: 10.1097/FPC.0000000000000112.

Aquagenic wrinkling of the palms in a patient with cystic fibrosis.

N Engl J Med. 2013 Dec 12;369(24):2362-3. doi: 10.1056/NEJMc1308349.

False dawn for cystic fibrosis disease modifiers?

Nat Rev Drug Discov. 2014 Oct;13(10):713-4. doi: 10.1038/nrd4456.

Cystic fibrosis transmembrane conductance regulator biomarkers in 'real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?

Ther Adv Respir Dis. 2015 Aug;9(4):198-200. doi: 10.1177/1753465815579364.

Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis.

Sci Transl Med. 2016 Jun 22;8(344):344ra84. doi: 10.1126/scitranslmed.aad8278.

Breathing easier with combinations.

Nat Biotechnol. 2015 Nov;33(11):1128-30. doi: 10.1038/nbt.3397.

CFTR potentiators: not an open and shut case.

Sci Transl Med. 2014 Jul 23;6(246):246fs27. doi: 10.1126/scitranslmed.3009674.

Lumacaftor alone and combined with ivacaftor: preclinical and clinical trial experience of F508del CFTR correction.

Expert Rev Respir Med. 2016;10(1):5-17. doi: 10.1586/17476348.2016.1122527. Epub 2015 Dec 9.

引用本文的文献

Patient-Derived Tumor Organoids: A Platform for Precision Therapy of Colorectal Cancer.

Cell Transplant. 2025 Jan-Dec;34:9636897251314645. doi: 10.1177/09636897251314645.

Landscape of human organoids: Ideal model in clinics and research.

Innovation (Camb). 2024 Apr 1;5(3):100620. doi: 10.1016/j.xinn.2024.100620. eCollection 2024 May 6.

3-D retina organoids: Building platforms for therapies of the future.

Cell Med. 2018 Jun 8;10:2155179018773758. doi: 10.1177/2155179018773758. eCollection 2018.

Copper Transport and Disease: What Can We Learn from Organoids?

Annu Rev Nutr. 2019 Aug 21;39:75-94. doi: 10.1146/annurev-nutr-082018-124242. Epub 2019 May 31.

Organoids Provide an Important Window on Inflammation in Cancer.

Cancers (Basel). 2018 May 21;10(5):151. doi: 10.3390/cancers10050151.

Scalable Production and Cryostorage of Organoids Using Core-Shell Decoupled Hydrogel Capsules.

Adv Biosyst. 2017 Dec;1(12). doi: 10.1002/adbi.201700165. Epub 2017 Nov 22.